• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human LIN7A Polyclonal Antibody

The antibody against LIN7A was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 1-90 of human LIN7A (NP_004655.1) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, ELISA.

ADA-05124A

The antibody against LIN7A was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 1-90 of human LIN7A (NP_004655.1) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, ELISA.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADA-05124A ClonalityPolyclonal
Host SpeciesRabbitTarget NameLIN7A
Target SynonymsLIN7; MALS1; VELI1; LIN-7A; MALS-1; TIP-33; LIN7AFormLiquid
Species ReactivityHuman, Mouse, RatIsotypeIgG
Storage Buffer50% Glycerol, PBS with 0.01% thimerosal, pH7.3.Purification MethodAffinity purification
Positive SamplesMouse kidney, Rat brain, 293T, MCF7, Mouse brain, Mouse eyeApplicationELISA, WB

Immunogen Information


Immunogen DescriptionRecombinant fusion protein containing a sequence corresponding to amino acids 1-90 of human LIN7A (NP_004655.1).Target SpeciesHuman
Immunogen SequenceMLKPSVTSAPTADMATLTVVQPLTLDRDVARAIELLEKLQESGEVPVHKLQSLKKVLQSEFCTAIREVYQYMHETITVNGCPEFRARATAUniprot IDO14910
Background Information
  • Uniprot Id

    O14910

  • Target Species

    Human

  • Target Name

    LIN7A

  • Target Full Name

    Protein lin-7 homolog A

  • Target Function

    Plays a role in establishing and maintaining the asymmetric distribution of channels and receptors at the plasma membrane of polarized cells. Forms membrane-associated multiprotein complexes that may regulate delivery and recycling of proteins to the correct membrane domains. The tripartite complex composed of LIN7 (LIN7A, LIN7B or LIN7C), CASK and APBA1 associates with the motor protein KIF17 to transport vesicles containing N-methyl-D-aspartate (NMDA) receptor subunit NR2B along microtubules. This complex may have the potential to couple synaptic vesicle exocytosis to cell adhesion in brain. Ensures the proper localization of GRIN2B (subunit 2B of the NMDA receptor) to neuronal postsynaptic density and may function in localizing synaptic vesicles at synapses where it is recruited by beta-catenin and cadherin. Required to localize Kir2 channels, GABA transporter (SLC6A12) and EGFR/ERBB1, ERBB2, ERBB3 and ERBB4 to the basolateral membrane of epithelial cells.

  • Target Subcellular Location

    Cell membrane; Peripheral membrane protein. Basolateral cell membrane; Peripheral membrane protein. Cell junction. Cell junction, synapse, postsynaptic density membrane; Peripheral membrane protein. Cell junction, tight junction.

  • Target Protein Families

    Lin-7 family

  • Target Tissue Specificity

    Expressed in brain, testis, kidney, placenta and liver.

  • Target Synonyms

    hLin-7; Lin 7 homolog A (C. elegans); LIN 7A; Lin-7A; LIN7; LIN7A; LIN7A_HUMAN; MALS-1; Mammalian LIN 7 1; Mammalian lin-seven protein 1; Protein lin-7 homolog A; Tax interaction protein 33; TIP-33; Veli-1; VELI1; Vertebrate lin-7 homolog 1; Vertebrate LIN7 homolog 1

  • Target Background

    The protein encoded by this gene is involved in generating and maintaining the asymmetric distribution of channels and receptors at the cell membrane. The encoded protein also is required for the localization of some specific channels and can be part of a protein complex that couples synaptic vesicle exocytosis to cell adhesion in the brain.

Inquire Rabbit anti-Human LIN7A Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification